Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
Yangyang Liu(First Affiliated Hospital of Zhengzhou University), Ying Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Jiaran Lin(Beijing Hospital of Traditional Chinese Medicine), Linhua Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaowen Gou(Chinese Academy of Medical Sciences & Peking Union Medical College), Chensi Yao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jixiang Ren(The Affiliated Hospital to Changchun University of Chinese Medicine), Cheng Tang(National Institute for Materials Science), Zezheng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian Wang(Ningbo University of Technology), Linlin Sun(Guangxi Medical University), Dan Liu(Machine Intelligence Research Institute), Xi Chen(Karolinska Institutet), Min Li(Xi'an Jiaotong University), Jia Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Han(Istituto di Scienze Marine del Consiglio Nazionale delle Ricerche), Keyu Chen(Ningbo University), Haoyu Yang(Army Medical University), Qiyou Ding(Beijing Hospital of Traditional Chinese Medicine), Yu Wei(Beijing Hospital of Traditional Chinese Medicine), Hongan Wang(The Affiliated Hospital to Changchun University of Chinese Medicine)
Cited by 3
Related Papers
Boron Nitride Nanotubes
|Advanced Materials|2007|968
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|405
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387